RxAnte

Portland, ME · Founded 2011 · Acquired/Merged (Operating Subsidiary)

Provider of predictive analytics and targeted clinical programs intended to improve medication prescribing and adherence. RxAnte is based in Portland, ME and was founded in 2011. Its last known valuation is $28.9 million (Nov 2020). It has raised $49.8 million across 1 recorded round; the latest was a $10.9 million debt round in Oct 2020.

Last price · $/share
—
Implied valuation
$28.9M
Total raised
$49.8M
Last round
Debt
Oct 2020

Who backs RxAnte?

4 investors
InvestorType
First Trust Capital PartnersVenture capital
PNC Erieview CapitalOther
Primus Capital—
Trinity Capital (Phoenix)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

RxAnte investors

4 investors are on record for RxAnte, including First Trust Capital Partners, PNC Erieview Capital, Primus Capital and Trinity Capital (Phoenix). The debt round in Oct 2020 drew 7 investors.

Free account
More of RxAnte with a free account
  • ·Watch RxAnte: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like RxAnte. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View